Latest Investment News

Papyrus Australia reported a $52,000 operating cash outflow for April 2025 but bolstered its liquidity with $239,000 in financing inflows, extending its funding runway to over a year.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Mount Hope Mining Limited has announced a non-renounceable pro-rata Loyalty Option Offer to raise approximately $103,125, aiming to bolster exploration funding and reward shareholder loyalty.

Tamboran Resources has successfully closed the first tranche of its PIPE, raising US$38.7 million to advance its Beetaloo Basin projects, with a second tranche pending shareholder approval.

Austco Healthcare has completed its strategic acquisition of New Zealand’s G&S Technologies, enhancing its healthcare communication offerings and direct sales reach in the region.

Merchant House International Limited reported a 38% reduction in net loss for FY2025, driven by asset sales and operational wind-down. The company is moving towards divesting remaining assets, delisting from ASX, and winding up.

Manuka Resources has announced a comprehensive 10-year mine plan to produce 13.2 million ounces of silver plus gold credits from its Wonawinta and Mt Boppy projects, leveraging existing infrastructure and an upgraded processing plant.

Orbminco Limited has initiated geophysical surveys at its Bronze Fox Copper-Gold Project in Mongolia, setting the stage for a targeted drilling program in Q3 2025 focused on high-grade copper-gold zones.

Beamtree Holdings has forged a strategic alliance with the NHS Confederation to launch a pioneering healthcare analytics platform across UK NHS Trusts, marking a significant step in its international expansion.

Havilah Resources reports significant progress on its copper-gold-cobalt projects Kalkaroo and Mutooroo, alongside promising regional exploration and strategic funding efforts.

Little Green Pharma Ltd has reported a robust turnaround for FY2025, posting a $3.3 million profit after tax on revenues up 43%, driven by strong growth in Australia and Europe and strategic acquisitions.

Aguia Resources Limited has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at a discount, aiming to raise up to $3 million to advance its phosphate and gold exploration projects.